Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 30, 2018	Apr. 30, 2017
Current Assets
Cash and cash equivalents	$ 9,716	$ 12,506
Restricted cash	1,242	1,435
Receivables, less allowance: $384 (2018); $191 (2017)	32,660	29,889
Inventories	17,662	14,935
Prepaid expenses and other current assets	2,224	1,047
Total Current Assets	63,504	59,812
Property, Plant and Equipment, Net	14,661	14,027
Other Assets
Deferred income taxes	2,031	3,158
Other	4,162	3,919
Total Other Assets	6,193	7,077
Total Assets	84,358	80,916
Current Liabilities
Short-term borrowings and interest rate swaps	3,885	3,591
Current portion of long-term debt	1,167	918
Accounts payable	14,754	11,995
Employee compensation and amounts withheld	3,810	2,765
Deferred revenue	1,884	5,806
Other accrued expenses	2,062	1,852
Total Current Liabilities	27,562	26,927
Long-term debt	1,264	2,431
Accrued pension and deferred compensation costs	7,465	8,301
Income taxes payable	546
Total Liabilities	36,837	37,659
Commitments and Contingencies (Note 7)
Stockholders' Equity
Common stock, $2.50 par value, Authorized-5,000 shares; Issued-2,736 shares (2018); 2,715 shares; (2017); Outstanding-2,733 shares (2018); 2,712 shares (2017);	6,841	6,789
Additional paid-in-capital	3,006	2,695
Retained earnings	43,165	39,771
Accumulated other comprehensive loss	(5,900)	(6,319)
Common stock in treasury, at cost: 3 shares	(53)	(53)
Total Kewaunee Scientific Corporation Stockholders' Equity	47,059	42,883
Noncontrolling Interest	462	374
Total Equity	47,521	43,257
Total Liabilities and Stockholders' Equity	$ 84,358	$ 80,916